0000899243-16-026532.txt : 20160808 0000899243-16-026532.hdr.sgml : 20160808 20160808173054 ACCESSION NUMBER: 0000899243-16-026532 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20160728 FILED AS OF DATE: 20160808 DATE AS OF CHANGE: 20160808 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Unilife Corp CENTRAL INDEX KEY: 0001476170 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 271049354 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 250 CROSS FARM LANE CITY: YORK STATE: PA ZIP: 17406 BUSINESS PHONE: (717) 384-3400 MAIL ADDRESS: STREET 1: 250 CROSS FARM LANE CITY: YORK STATE: PA ZIP: 17406 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Weaver Molly CENTRAL INDEX KEY: 0001681038 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34540 FILM NUMBER: 161815343 MAIL ADDRESS: STREET 1: 250 CROSS FARM LANE CITY: YORK STATE: PA ZIP: 17406 3 1 doc3.xml FORM 3 SUBMISSION X0206 3 2016-07-28 0 0001476170 Unilife Corp UNIS 0001681038 Weaver Molly 250 CROSS FARM LANE YORK PA 17406 0 1 0 0 See Remarks Common Stock 43207 D Common Stock 43613 I By spouse. Employee Stock Option (right to buy) 48.40 2021-04-18 Common Stock 7500 D Of these shares of common stock of Unilife Corporation (the "Company"), 594 shares were awarded by the Company to the reporting person on April 14, 2014 and are scheduled to vest on April 30, 2017 subject to the reporting person's continued employment with the Company as of such date. Of these shares of common stock of the Company, 500 shares were awarded by the Company to the reporting person's spouse on April 15, 2014 and are scheduled to vest on April 30, 2017. Of these shares, 23,188 represent restricted stock units awarded by the Company to the reporting person's spouse on June 30, 2016, 5,797 of which are scheduled to vest on June 1, 2017, 5,797 of which are scheduled to vest on June 1, 2018, and 11,594 of which are scheduled to vest on June 1, 2019, in each case, subject to the reporting person's continued employment with the Company as of the applicable date. On April 18, 2011, the reporting person was granted an option to purchase 7,500 shares of common stock of the Company. The option could vest based on the Company's satisfaction of certain performance criteria through April 18, 2021. Certain performance criteria was met in fiscal year 2013, resulting in vesting of the option as to 2,000 shares. VP Quality and Regulatory Affairs & CCO /s/ Kevin Campbell, as attorney-in-fact 2016-08-08 EX-24.1 2 attachment1.htm EX-24.1 DOCUMENT
                                                                    Exhibit 24.1

                            LIMITED POWER OF ATTORNEY
                           FOR SECTION 16(a) REPORTING

        KNOW ALL PERSONS BY THESE PRESENTS, that the undersigned hereby makes,
constitutes and appoints Kevin Campbell and Stephanie Walters, as the
undersigned's true and lawful attorney-in-fact (the "Attorney-in-Fact"), with
full power of substitution and resubstitution, with the power to act alone for
the undersigned and in the undersigned's name, place and stead, in any and all
capacities to:

   1.   prepare, execute and file with the Securities and Exchange Commission
        (the "SEC"), any national securities exchange or securities quotation
        system and Unilife Corporation (the "Company"), any and all reports
        (including any amendment thereto) of the undersigned required or
        considered advisable under Section 16(a) ("Section 16(a)") of the
        Securities Exchange Act of 1934, as amended (the "Exchange Act"), and
        the rules and regulations thereunder, with respect to the equity
        securities of the Company, including Forms 3, 4 and 5 in accordance
        with Section 16(a);

   2.   obtain, as the undersigned's representative and on the undersigned's
        behalf, information regarding transactions in the Company's equity
        securities from any third party, including the Company and any
        brokers, dealers, employee benefit plan administrators and trustees,
        and the undersigned hereby authorizes any such third party to release
        any such information to the Attorney-in-Fact;

   3.   do and perform any and all acts for and on behalf of the undersigned
        which may be necessary or desirable to complete and execute any Form
        3, 4, or 5 in accordance with Section 16(a), complete and execute any
        amendment or amendments thereto, and timely file such form with the
        SEC and any stock exchange or similar authority; and

   4.   take any other action of any type whatsoever in connection with the
        foregoing which, in the opinion of such Attorney-in-Fact, may be of
        benefit to, in the best interest of, or legally required by, the
        undersigned, it being understood that the documents executed by the
        Attorney-in-Fact on behalf of the undersigned pursuant to this Limited
        Power of Attorney shall be in such form and shall contain such terms
        and conditions as the Attorney-in-Fact may approve in his or her
        discretion.

The undersigned acknowledges that:

   1.   this Limited Power of Attorney authorizes, but does not require, the
        Attorney-in-Fact to act at his or her discretion on information
        provided to such Attorney-in-Fact without independent verification of
        such information;

   2.   any documents prepared or executed by the Attorney-in-Fact on behalf
        of the undersigned pursuant to this Limited Power of Attorney will be
        in such form and will contain such information as the
        Attorney-in-Fact, in his or her discretion, deems necessary or
        desirable;

   3.   neither the Company nor the Attorney-in-Fact assumes any liability for
        the undersigned's responsibility to comply with the requirements of
        Section 16 of the Exchange Act, any liability of the undersigned for
        any failure to comply with such requirements, or any liability of the
        undersigned for disgorgement of profits under Section 16(b) of the
        Exchange Act; and

   4.   this Limited Power of Attorney does not relieve the undersigned from
        responsibility for compliance with the undersigned's obligations under
        Section 16 of the Exchange Act, including, without limitation, the
        reporting requirements under Section 16(a).

The undersigned hereby grants to the Attorney-in-Fact full power and authority
to do and perform each and every act and thing requisite, necessary or
convenient to be done in connection with the foregoing, as fully, to all intents
and purposes, as the undersigned might or could do in person, hereby ratifying
and confirming all that the Attorney-in-Fact, or his or her substitute or
substitutes, shall lawfully do or cause to be done by authority of this Limited
Power of Attorney.

This Limited Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4 or 5 in accordance with
Section 16(a) with respect to the undersigned's transactions in equity
securities of the Company, unless earlier revoked by the undersigned in a signed
writing delivered to the Attorney-in-Fact.

IN WITNESS WHEREOF, the undersigned has executed this Limited Power of Attorney
as of August 8, 2016.

                                        By: /s/ Molly Weaver
                                           ------------------------------------
                                        Name: Molly Weaver